$CBNT
C-Bond Systems, Inc Stock $cbnt

$cbnt Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000121390023025315 Filed on March 31, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$515.2K	$607.9K	$2.233M
YoY Change	0.88%	18.51%	51.18%
Cost Of Revenue	$245.4K	$248.7K	$954.4K
YoY Change	-1.71%	-29.57%	45.2%
Gross Profit	$269.9K	$359.2K	$1.278M
YoY Change	3.36%	124.71%	55.97%
Gross Profit Margin	52.38%	59.09%	57.25%
Selling, General & Admin	$785.2K	$957.3K	$4.432M
YoY Change	-59.2%	-22.3%	-43.24%
% of Gross Profit	290.98%	266.49%	346.73%
Research & Development	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
% of Gross Profit	0.0%	0.0%	0.0%
Depreciation & Amortization	$20.85K	$20.99K	$89.22K
YoY Change	-8.99%	73.61%	94.08%
% of Gross Profit	7.73%	5.84%	6.98%
Operating Expenses	$793.5K	$965.6K	$4.471M
YoY Change	-58.99%	-22.24%	-42.9%
Operating Profit	-$523.6K	-$606.4K	-$3.192M
YoY Change	-68.72%	-43.96%	-54.46%
Interest Expense	$195.8K	-$562.4K	$1.610M
YoY Change	-178.76%	168.44%	-669.01%
% of Operating Profit
Other Income/Expense, Net	-$199.5K	$0.00	$0.00
YoY Change			-100.0%
Pretax Income	-$723.1K	-$1.281M	-$5.156M
YoY Change	-62.33%	7.22%	-27.67%
Income Tax			-$1.081M
% Of Pretax Income
Net Earnings	-$723.1K	-$1.288M	-$5.156M
YoY Change	-62.33%	9.5%	-27.82%
Net Earnings / Revenue	-140.35%	-211.91%	-230.96%
Basic Earnings Per Share	$0.00		-$0.02
Diluted Earnings Per Share	$0.00	$0.00	-$0.02
COMMON SHARES
Basic Shares Outstanding	447.7M shares	328.7M shares	308.1M shares
Diluted Shares Outstanding	425.0M shares		308.1M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$82.98K	$97.09K	$97.09K
YoY Change	-51.22%	-81.33%	-81.33%
Cash & Equivalents	$82.98K	$97.09K
Short-Term Investments
Other Short-Term Assets	$88.85K	$71.17K	$71.17K
YoY Change	124.26%	-53.1%	-53.1%
Inventory	$59.35K	$77.45K	$77.45K
Prepaid Expenses
Receivables	$198.7K	$269.7K	$269.7K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$429.9K	$515.4K	$515.4K
YoY Change	-26.76%	-49.19%	-49.19%
LONG-TERM ASSETS
Property, Plant & Equipment	$88.08K	$96.31K	$471.7K
YoY Change	-77.39%	-28.67%	22.15%
Goodwill	$350.5K	$350.5K
YoY Change		0.0%
Intangibles	$267.3K	$279.9K
YoY Change		-15.28%
Long-Term Investments	$7.780K	$6.480K	$6.480K
YoY Change	20.06%	0.0%	0.0%
Other Assets		$1.109M
YoY Change
Total Long-Term Assets	$1.060M	$1.109M	$1.109M
YoY Change	-0.37%	3.26%	3.26%
TOTAL ASSETS
Total Short-Term Assets	$429.9K	$515.4K	$515.4K
Total Long-Term Assets	$1.060M	$1.109M	$1.109M
Total Assets	$1.490M	$1.624M	$1.624M
YoY Change	-9.75%	-22.22%	-22.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$828.5K	$779.8K	$779.8K
YoY Change	-2.91%	-6.24%	-6.24%
Accrued Expenses	$859.5K	$736.4K	$1.455M
YoY Change	-8.31%	68.61%	23.99%
Deferred Revenue		$22.64K
YoY Change
Short-Term Debt	$1.195M	$1.031M	$1.031M
YoY Change	215.98%	499.98%	499.98%
Long-Term Debt Due	$1.592M	$1.576M	$1.576M
YoY Change	148.78%	222.77%	222.77%
Total Short-Term Liabilities	$5.020M	$4.865M	$4.865M
YoY Change	75.85%	81.82%	81.82%
LONG-TERM LIABILITIES
Long-Term Debt	$625.7K	$710.1K	$710.1K
YoY Change	17.99%	31.63%	31.63%
Other Long-Term Liabilities	$227.7K	$258.9K	$258.9K
YoY Change	8.16%	25.48%	25.48%
Total Long-Term Liabilities	$853.4K	$969.0K	$969.0K
YoY Change	15.19%	29.93%	29.93%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.020M	$4.865M	$4.865M
Total Long-Term Liabilities	$853.4K	$969.0K	$969.0K
Total Liabilities	$5.874M	$5.834M	$5.985M
YoY Change	55.72%	70.51%	65.75%
SHAREHOLDERS EQUITY
Retained Earnings	-$63.41M	-$62.69M
YoY Change		9.0%
Common Stock	$447.7K	$350.3K
YoY Change		24.11%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$4.518M	-$7.201M	-$4.360M
YoY Change
Total Liabilities & Shareholders Equity	$1.490M	$1.624M	$1.624M
YoY Change	-9.75%	-22.22%	-22.22%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$723.1K	-$1.288M	-$5.156M
YoY Change	-62.33%	9.5%	-27.82%
Depreciation, Depletion And Amortization	$20.85K	$20.99K	$89.22K
YoY Change	-8.99%	73.61%	94.08%
Cash From Operating Activities	-$291.0K	-$401.8K	-$1.585M
YoY Change	-42.24%	-22.49%	-12.29%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities		$5.500K	$5.500K
YoY Change		-57.69%	-98.18%
Cash From Investing Activities		$5.500K	$5.500K
YoY Change		-57.69%	-98.18%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$276.9K	340.8K	$1.157M
YoY Change	79.81%	-48.12%	-32.03%
NET CHANGE
Cash From Operating Activities	-$291.0K	-401.8K	-$1.585M
Cash From Investing Activities		5.500K	$5.500K
Cash From Financing Activities	$276.9K	340.8K	$1.157M
Net Change In Cash	-$14.11K	-55.48K	-$422.8K
YoY Change	-95.97%	-136.6%	-315.18%
FREE CASH FLOW
Cash From Operating Activities	-$291.0K	-$401.8K	-$1.585M
Capital Expenditures
Free Cash Flow			-$1.585M
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Security12b Title Security12bTitle	N/A
CY2022	dei	Trading Symbol TradingSymbol	N/A
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	000-53029
CY2022	dei	Entity Registrant Name EntityRegistrantName	C-BOND SYSTEMS, INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	CO
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-1315585
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	6035 South Loop East
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Houston
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	77033
CY2022	dei	City Area Code CityAreaCode	(832)
CY2022	dei	Local Phone Number LocalPhoneNumber	649-5658
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	2695967	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	447704272	shares
CY2022	dei	Auditor Firm AuditorFirmId	106
CY2022	dei	Auditor Name AuditorName	SALBERG & COMPANY, P.A.
CY2022	dei	Auditor Location AuditorLocation	Boca Raton, Florida
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	97091	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	519898	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	269442	usd
CY2021Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	173248	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	77446	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	82931	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	71171	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	151746	usd
CY2022Q4	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	279	usd
CY2021Q4	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	82805	usd
CY2021Q4	us-gaap	Due From Related Parties DueFromRelatedParties	3750	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	515429	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	1014378	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	96306	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	135022	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	375412	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	251172	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	279918	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	330421	usd
CY2022Q4	us-gaap	Goodwill Goodwill	350491	usd
CY2021Q4	us-gaap	Goodwill Goodwill	350491	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	6482	usd
CY2021Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	6482	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	1108609	usd
CY2021Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	1073588	usd
CY2022Q4	us-gaap	Assets Assets	1624038	usd
CY2021Q4	us-gaap	Assets Assets	2087966	usd
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1031250	usd
CY2021Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	171875	usd
CY2022Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	1576438	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	488414	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	779765	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	831648	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	736393	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	436733	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	10027	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	590632	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	691602	usd
CY2022Q4	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	22637	usd
CY2021Q4	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	10426	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	117671	usd
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	44927	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4864813	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2675625	usd
CY2022Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	251263	usd
CY2022Q4	us-gaap	Other Long Term Notes Payable OtherLongTermNotesPayable	208804	usd
CY2021Q4	us-gaap	Other Long Term Notes Payable OtherLongTermNotesPayable	539440	usd
CY2022Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	250000	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	258895	usd
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	206319	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	968962	usd
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	745759	usd
CY2022Q4	us-gaap	Liabilities Liabilities	5833775	usd
CY2021Q4	us-gaap	Liabilities Liabilities	3421384	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	1037201	usd
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	738611	usd
CY2022Q4	cbnt	Temporary Equity Carrying Amount Attributable To Parent One TemporaryEquityCarryingAmountAttributableToParentOne	1803731	usd
CY2021Q4	cbnt	Temporary Equity Carrying Amount Attributable To Parent One TemporaryEquityCarryingAmountAttributableToParentOne	1907012	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.1
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.1
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	4998000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	4998000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	350270172	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	350270172	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	282216632	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	282216632	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	350270	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	282217	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	55141503	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	53064616	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-62693184	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-57515129	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-7201411	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-4168296	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	150742	usd
CY2021Q4	us-gaap	Minority Interest MinorityInterest	189255	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-7050669	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3979041	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1624038	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2087966	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2232646	usd
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1475628	usd
CY2021	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	1200	usd
CY2022	us-gaap	Revenues Revenues	2232646	usd
CY2021	us-gaap	Revenues Revenues	1476828	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	954402	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	657298	usd
CY2022	us-gaap	Gross Profit GrossProfit	1278244	usd
CY2021	us-gaap	Gross Profit GrossProfit	819530	usd
CY2022	us-gaap	Employee Benefits And Share Based Compensation Noncash EmployeeBenefitsAndShareBasedCompensationNoncash	1039943	usd
CY2021	us-gaap	Employee Benefits And Share Based Compensation Noncash EmployeeBenefitsAndShareBasedCompensationNoncash	4085868	usd
CY2022	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	2844783	usd
CY2021	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	6165006	usd
CY2021	cbnt	Research And Developments ResearchAndDevelopments	3250	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	815542	usd
CY2021	us-gaap	Professional Fees ProfessionalFees	1031540	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	810413	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	636353	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	4470738	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	7829649	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-3192494	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-7010119	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-343895	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	96442	usd
CY2021	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	67778	usd
CY2022	us-gaap	Interest Expense InterestExpense	1610062	usd
CY2021	us-gaap	Interest Expense InterestExpense	282959	usd
CY2022	cbnt	Interest Expenses Related Party InterestExpensesRelatedParty	10027	usd
CY2022	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-1963984	usd
CY2021	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-118739	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-5156478	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-7128858	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-38513	usd
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	15525	usd
CY2022	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	60090	usd
CY2021	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	4401907	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5178055	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11546290	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	308121062	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	254299139	shares
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3167220	usd
CY2021	cbnt	Common Shares Issued For Accounts Payable CommonSharesIssuedForAccountsPayable	117838	usd
CY2021	cbnt	Common Stock Issued For Acquisition CommonStockIssuedForAcquisition	694921	usd
CY2021	cbnt	Common Shares Issued For Professional Fees CommonSharesIssuedForProfessionalFees	554200	usd
CY2021	cbnt	Common Shares Issued For Compensation CommonSharesIssuedForCompensation	24413	usd
CY2021	cbnt	Shares Issued For Conversion Of Accrued Compensation SharesIssuedForConversionOfAccruedCompensation	55741	usd
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	12000	usd
CY2021	cbnt	Common Stock Issued In Connection With Convertible Debt CommonStockIssuedInConnectionWithConvertibleDebt	14064	usd
CY2021	cbnt	Preferred Stock Dividends And Deemed Dividend PreferredStockDividendsAndDeemedDividend	-47146	usd
CY2021	cbnt	Adjustments To Additional Paid In Capital Accretion Of Stock Based Compensation AdjustmentsToAdditionalPaidInCapitalAccretionOfStockBasedCompensation	267530	usd
CY2021	cbnt	Stock Issued During Period Value Accretion Of Stockbased Professional Fees StockIssuedDuringPeriodValueAccretionOfStockbasedProfessionalFees	5000	usd
CY2021	cbnt	Beneficial Conversion Charge For Issuance Of Series B Preferred Shares For Accrued Compensation BeneficialConversionChargeForIssuanceOfSeriesBPreferredSharesForAccruedCompensation	3778810	usd
CY2021	cbnt	Initial Noncontrolling In Acquired Business InitialNoncontrollingInAcquiredBusiness	173730	usd
CY2021	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	318794	usd
CY2021	cbnt	Issuance Of Warrant In Connection With Convertible Debt IssuanceOfWarrantInConnectionWithConvertibleDebt	347142	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-7128858	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3979041	usd
CY2022	cbnt	Common Shares Issued For Accounts Payable CommonSharesIssuedForAccountsPayable	2174	usd
CY2022	cbnt	Common Shares Issued For Compensation CommonSharesIssuedForCompensation	14250	usd
CY2022	cbnt	Common Shares Issued For Professional Fees CommonSharesIssuedForProfessionalFees	217250	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	139000	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	110631	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	112500	usd
CY2022	cbnt	Preferred Stock Dividends And Deemed Dividend PreferredStockDividendsAndDeemedDividend	-55655	usd
CY2022	cbnt	Adjustments To Additional Paid In Capital Accretion Of Stock Based Compensation AdjustmentsToAdditionalPaidInCapitalAccretionOfStockBasedCompensation	68137	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	325785	usd
CY2022	cbnt	Beneficial Conversion Charge For Issuance Of Series B Preferred Shares For Accrued Compensation BeneficialConversionChargeForIssuanceOfSeriesBPreferredSharesForAccruedCompensation	957556	usd
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	354215	usd
CY2022	cbnt	Extinguishment Loss Related To Conversion Of Debt ExtinguishmentLossRelatedToConversionOfDebt	-160993	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-5156478	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-7050669	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-5156478	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-7128858	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	89219	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	45967	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1059752	usd
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	171875	usd
CY2022	us-gaap	Paid In Kind Interest PaidInKindInterest	90731	usd
CY2022	cbnt	Default Penalty Included In Interest Expense DefaultPenaltyIncludedInInterestExpense	206250	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	1039943	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	4085868	usd
CY2022	cbnt	Stockbased Professional Fee StockbasedProfessionalFee	298571	usd
CY2021	cbnt	Stockbased Professional Fee StockbasedProfessionalFee	478129	usd
CY2022	cbnt	Bad Debt Expense BadDebtExpense	7716	usd
CY2021	cbnt	Bad Debt Expense BadDebtExpense	39355	usd
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	45000	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	5500	usd
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	13000	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-343895	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	96442	usd
CY2022	cbnt	Increase Decrease In Lease Cost IncreaseDecreaseInLeaseCost	1080	usd
CY2021	cbnt	Increase Decrease In Lease Cost IncreaseDecreaseInLeaseCost	-370	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	100160	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	73180	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-5485	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-17288	usd
CY2022	cbnt	Prepaid Expenses And Other Assets PrepaidExpensesAndOtherAssets	-746	usd
CY2021	cbnt	Prepaid Expenses And Other Assets PrepaidExpensesAndOtherAssets	-13211	usd
CY2022	cbnt	Costs And Estimated Earnings In Excess CostsAndEstimatedEarningsInExcess	-82526	usd
CY2021	cbnt	Costs And Estimated Earnings In Excess CostsAndEstimatedEarningsInExcess	50106	usd
CY2021	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	-1776	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-49709	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	88853	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	299660	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	92148	usd
CY2022	us-gaap	Increase Decrease In Due To Other Related Parties IncreaseDecreaseInDueToOtherRelatedParties	10027	usd
CY2021	cbnt	Increase Decrease In Customer Deposit IncreaseDecreaseInCustomerDeposit	-110000	usd
CY2022	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	180609	usd
CY2021	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	601431	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	12211	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	10426	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1584918	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1807051	usd
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	5500	usd
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	13000	usd
CY2021	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	288901	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	5500	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	301901	usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	250000	usd
CY2021	cbnt	Proceeds From Sale Of Series C Preferred Stock ProceedsFromSaleOfSeriesCPreferredStock	550000	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	903760	usd
CY2021	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	500000	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	157149	usd
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	28359	usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	160000	usd
CY2021	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	680000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1156611	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1701641	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-422807	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	196491	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	519898	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	323407	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	97091	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	519898	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	479509	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	53283	usd
CY2022	cbnt	Common Stock Issued As Prepaid For Services CommonStockIssuedAsPrepaidForServices	217250	usd
CY2021	cbnt	Common Stock Issued As Prepaid For Services CommonStockIssuedAsPrepaidForServices	98800	usd
CY2021	cbnt	Common Stock Issued For Accrued Compensation CommonStockIssuedForAccruedCompensation	40626	usd
CY2022	cbnt	Series B Preferred Stock Issued For Accrued Compensation SeriesBPreferredStockIssuedForAccruedCompensation	278654	usd
CY2021	cbnt	Series B Preferred Stock Issued For Accrued Compensation SeriesBPreferredStockIssuedForAccruedCompensation	295000	usd
CY2022	cbnt	Common Stock Issued For Accouts Payable CommonStockIssuedForAccoutsPayable	2174	usd
CY2021	cbnt	Common Stock Issued For Accouts Payable CommonStockIssuedForAccoutsPayable	117838	usd
CY2022	cbnt	Preferred Stock Dividend Accrued PreferredStockDividendAccrued	55655	usd
CY2021	cbnt	Preferred Stock Dividend Accrued PreferredStockDividendAccrued	47146	usd
CY2021	cbnt	Deemed Dividend Related To Beneficial Conversion Feature Of Series C Preferred Shares DeemedDividendRelatedToBeneficialConversionFeatureOfSeriesCPreferredShares	4354761	usd
CY2022	cbnt	Increase In Debt Discount And Paidin Capital For Beneficial Conversion Feature On Convertible Debt IncreaseInDebtDiscountAndPaidinCapitalForBeneficialConversionFeatureOnConvertibleDebt	110631	usd
CY2022	cbnt	Increase In Debt Discount And Paidin Capital For Warrants Issued With Convertible Debt IncreaseInDebtDiscountAndPaidinCapitalForWarrantsIssuedWithConvertibleDebt	680000	usd
CY2021	cbnt	Increase In Debt Discount And Paidin Capital For Warrants Issued With Convertible Debt IncreaseInDebtDiscountAndPaidinCapitalForWarrantsIssuedWithConvertibleDebt	680000	usd
CY2022	cbnt	Conversion Of Series C Preferred Stock To Common Stock ConversionOfSeriesCPreferredStockToCommonStock	139000	usd
CY2021	cbnt	Conversion Of Series C Preferred Stock To Common Stock ConversionOfSeriesCPreferredStockToCommonStock	12000	usd
CY2022	cbnt	Increase In Right Of Use And Lease Liability IncreaseInRightOfUseAndLeaseLiability	184375	usd
CY2021	cbnt	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCash	288901	usd
CY2021	cbnt	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivable	59726	usd
CY2021	cbnt	Business Combination Recognized Identifiable Assets Acquired And Liabilitie Assumed Inventory BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitieAssumedInventory	68019	usd
CY2021	cbnt	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Asset BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAsset	6091	usd
CY2021	cbnt	Contract Assets ContractAssets	32699	usd
CY2021	cbnt	Business Combination Recognized Identifiable Assets Acquired And Liabilitie Assumed Contract Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitieAssumedContractAssets	140211	usd
CY2021	cbnt	Business Combination Recognized Right Of Use Assets BusinessCombinationRecognizedRightOfUseAssets	253433	usd
CY2021	cbnt	Assets Acquired AssetsAcquired	849080	usd
CY2021	cbnt	Business Combination Recognized Accounts Payable BusinessCombinationRecognizedAccountsPayable	65728	usd
CY2021	cbnt	Business Combination Recognized Accrued Expenses BusinessCombinationRecognizedAccruedExpenses	159262	usd
CY2021	cbnt	Business Combination Recognized Notes Payable BusinessCombinationRecognizedNotesPayable	95013	usd
CY2021	cbnt	Business Combination Recognized Customer Deposit BusinessCombinationRecognizedCustomerDeposit	110000	usd
CY2021	cbnt	Business Combination Recognized I Lease Liabilities BusinessCombinationRecognizedILeaseLiabilities	253433	usd
CY2021	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	173730	usd
CY2021	cbnt	Business Combination Recognized Liabilities Assumed BusinessCombinationRecognizedLiabilitiesAssumed	857166	usd
CY2021	cbnt	Net Liabilitie Assumed NetLiabilitieAssumed	8086	usd
CY2021	cbnt	Fair Value Of Shares For Acquisition FairValueOfSharesForAcquisition	-694921	usd
CY2021	cbnt	Business Combination Recognized Increase In Intangible Assets Noncash BusinessCombinationRecognizedIncreaseInIntangibleAssetsNoncash	703007	usd
CY2022	us-gaap	Nature Of Operations NatureOfOperations	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 1 – <span style="text-decoration:underline">NATURE OF ORGANIZATION</span></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Nature of Organization</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">C-Bond Systems, Inc., together with its subsidiaries (the “Company”), is a materials development company and sole owner, developer, and manufacturer of the patented C-Bond technology. The Company is engaged in the implementation of proprietary nanotechnology applications and processes to enhance properties of strength, functionality, and sustainability of brittle material systems. The Company’s primary focus is in the multi-billion-dollar glass and window film industry with target markets in the United States and internationally. Additionally, the Company has expanded its product line to include disinfection products. The Company operates in two divisions: C-Bond Transportation Solutions and Patriot Glass Solutions. C-Bond Transportation Solutions sells a windshield strengthening, water repellent solution called C-Bond nanoShield™ as well as disinfection products. Patriot Glass Solutions sells multi-purpose glass strengthening primer and window film mounting solutions, including C-Bond BRS, a ballistic-resistant film system, and C-Bond Secure, a forced entry system.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 30, 2021, the Company entered into a Share Exchange Agreement and Plan of Reorganization (the “Exchange Agreement”) with (i) Mobile Tint LLC, a Texas limited liability company doing business as A1 Glass Coating (“Mobile”), (ii) the sole member of Mobile (the “Mobile Shareholder”), and (iii) Michael Wanke as the Representative of the Mobile Shareholder. Pursuant to the Exchange Agreement, the Company agreed to acquire 80% of Mobile’s units, representing 80% of Mobile’s issued and outstanding capital stock (the “Mobile Shares”). On July 22, 2021, the Company closed the Exchange Agreement and acquired 80% of the Mobile Shares. The Mobile Shares were exchanged for 28,021,016 restricted shares of the Company’s common stock in an amount equal to $800,000, divided by the average of the closing prices of the Company’s common stock during the 30-day period immediately prior to the closing. Two years after closing, the Company has the option to acquire the remaining 20% of Mobile’s issued and outstanding membership interests in exchange for a number of shares of the Company’s common stock equal to 300% of Mobile’s average EBIT value, divided by the price of the Company’s common stock as defined in the Exchange Agreement (the “Additional Closing”). Mobile provides quality window tint solutions for auto, home, and business owners across Texas, specializing in automotive window tinting, residential window film, and commercial window film that stop harmful UV rays from passing through its window films for reduced glare, comfortable temperatures, and lower energy bills. Mobile also carries products that offer forced-entry protection and films that protect glass from scratches, graffiti, other types of vandalism, and even bullets, including C-Bond BRS and C-Bond Secure products. As part of the transaction, Mobile’s owner-operator, Mr. Wanke, joined the Company as President of its Patriot Glass Solutions division.</p>
CY2021Q2	cbnt	Minority Interest Ownership Percentage MinorityInterestOwnershipPercentage	0.80	pure
CY2021Q2	cbnt	Issued And Outstanding Percent IssuedAndOutstandingPercent	0.80	pure
CY2021Q3	cbnt	Minority Interest Ownership Percentage MinorityInterestOwnershipPercentage	0.80	pure
CY2021Q3	cbnt	Restricted Shares Of Common Stock RestrictedSharesOfCommonStock	28021016	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Expected Dividend ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend	800000	usd
CY2021Q3	cbnt	Issued And Outstanding Interest IssuedAndOutstandingInterest	0.20	pure
CY2021Q3	cbnt	Common Stock Percentage CommonStockPercentage	3	pure
CY2021Q3	cbnt	Consolidated Financial Statements Percentage ConsolidatedFinancialStatementsPercentage	0.80	pure
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Use of Estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Estimates during the years ended December 31, 2022 and 2021 include estimates for allowance for doubtful accounts on accounts receivable, the estimates for obsolete or slow moving inventory, estimates used in the calculation of progress towards completion on uncompleted jobs, purchase price allocation of acquired businesses, the useful life of property and equipment, assumptions used in assessing impairment of long-term assets, the estimate of the fair value lease liability and related right of use asset, the valuation of redeemable and mandatorily redeemable preferred stock, the value of beneficial conversion features and deemed dividends, the valuation allowances for deferred tax assets, and the fair value of non-cash equity transactions.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022Q4	us-gaap	Accrued Liabilities For Commissions Expense And Taxes AccruedLiabilitiesForCommissionsExpenseAndTaxes	26648	usd
CY2021Q4	us-gaap	Accrued Liabilities For Commissions Expense And Taxes AccruedLiabilitiesForCommissionsExpenseAndTaxes	26733	usd
CY2022	cbnt	Beneficial Conversion Feature BeneficialConversionFeature	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Beneficial Conversion Feature</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Convertible debt includes conversion terms that are considered in the money compared to the market price of the stock on the date of the related agreement. The Company calculates the beneficial conversion feature and records a debt discount with the amount being amortized to interest expense over the term of the note.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	45455	usd
CY2021	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	15431	usd
CY2022	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	0	usd
CY2021	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	3250	usd
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3250	usd
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1618980671	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	484322168	shares
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables	59726	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Inventory BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory	68019	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets	6091	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets	32699	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment	140211	usd
CY2022	cbnt	Risk Factors Policy Textblock RiskFactorsPolicyTextblock	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Risk and Uncertainties</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In March 2020, the World Health Organization declared COVID-19 a global pandemic and recommended containment and mitigation measures worldwide. The Company was materially affected by the COVID-19 outbreak in 2020 and 2021 and the ultimate duration and severity of the outbreak and its impact on the economic environment and our business is uncertain. The Company saw a material decrease in sales from its international customers as a result of the unprecedented public health crisis from the COVID-19 pandemic and a decrease in domestic sales due to a decrease in business spending on discretionary items. As a result, during 2021 and 2020, the Company’s international customers delayed the ordering of products and delayed or defaulted on payment of balances due to the Company. The lack of collection of accounts receivable balances, which the Company believes was attributable to COVID-19, had a material impact on the cash flows of the Company. The Company believes that COVID-19 had minimal impact on its operations in 2022. The Company cannot estimate the future impact of the pandemic on its business. A severe or prolonged economic downturn could result in a variety of risks to the Company’s business, including weakened demand for its products and a decreased ability to raise additional capital when needed on acceptable terms, if at all. Currently, the Company is unable to estimate the impact of this event on its operations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p>
CY2021Q3	cbnt	Exchange Agreement Percentage ExchangeAgreementPercentage	0.80	pure
CY2021Q3	us-gaap	Dividends Common Stock Stock DividendsCommonStockStock	800000	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	694921	usd
CY2021Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.0248
CY2021Q3	us-gaap	Investment Company Investment Income Loss Ratio InvestmentCompanyInvestmentIncomeLossRatio	3	pure
CY2022	us-gaap	Payments For Rent PaymentsForRent	5600	usd
CY2022	cbnt	Exchange Agreement Description ExchangeAgreementDescription	The Company’s obligation as Guarantor of the Lease will terminate upon the occurrence of earlier of the following: (i) the date of Guarantor’s acquisition of 100% of the ownership interests of Mobile; (ii) the date that Guarantor beneficially owns less than an eighty percent (80%) ownership interest in Mobile; or (iii) two (2) years from and after the effective date of the guaranty.
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	288901	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Other Noncurrent Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets	253433	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill	352516	usd
CY2022	us-gaap	Goodwill Transfers GoodwillTransfers	350491	usd
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	1552087	usd
CY2022Q4	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	95013	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable	65728	usd
CY2022Q4	cbnt	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Accrued Expenses BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses	159262	usd
CY2022Q4	cbnt	Customer Deposit CustomerDeposit	110000	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Capital Lease Obligation BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation	253433	usd
CY2022Q4	us-gaap	Other Minority Interests OtherMinorityInterests	173730	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities	857166	usd
CY2022Q4	us-gaap	Assets Net AssetsNet	694921	usd
CY2022	cbnt	Fair Value Of Common Shares Issuedin Dollars Per Share FairValueOfCommonSharesIssuedinDollarsPerShare	694921	usd
CY2022	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	694921	usd
CY2021	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	2168863	usd
CY2021	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-7128027	usd
CY2021	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	-0.03
CY2022Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	304964	usd
CY2021Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	204804	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	35522	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	31556	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	269442	usd
CY2021Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	173248	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	7716	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	39355	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1501	usd
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	7141	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	75945	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	120790	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	77446	usd
CY2021Q4	us-gaap	Inventory Gross InventoryGross	127931	usd
CY2021Q4	us-gaap	Inventory Adjustments InventoryAdjustments	45000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	77446	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	82931	usd
CY2022Q4	us-gaap	General And Administrative Costs In Inventory Amount Remaining GeneralAndAdministrativeCostsInInventoryAmountRemaining	0	usd
CY2021Q4	us-gaap	General And Administrative Costs In Inventory Amount Remaining GeneralAndAdministrativeCostsInInventoryAmountRemaining	45000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	263930	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	264744	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	167624	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	129722	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	96306	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	135022	usd
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	5500	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	5500	usd
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	13000	usd
CY2021	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	13000	usd
CY2022	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	38716	usd
CY2021	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	23872	usd
CY2022	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P5Y
CY2022Q4	us-gaap	Finite Lived Customer Relationships Gross FiniteLivedCustomerRelationshipsGross	212516	usd
CY2021Q4	us-gaap	Finite Lived Customer Relationships Gross FiniteLivedCustomerRelationshipsGross	212516	usd
CY2022	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P5Y
CY2022	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	40000	usd
CY2021	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	40000	usd
CY2022Q4	us-gaap	Finite Lived Trade Names Gross FiniteLivedTradeNamesGross	100000	usd
CY2021Q4	us-gaap	Finite Lived Trade Names Gross FiniteLivedTradeNamesGross	100000	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	352516	usd
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	352516	usd
CY2022Q4	us-gaap	Accumulated Amortization Of Other Deferred Costs AccumulatedAmortizationOfOtherDeferredCosts	72598	usd
CY2021Q4	us-gaap	Accumulated Amortization Of Other Deferred Costs AccumulatedAmortizationOfOtherDeferredCosts	22095	usd
CY2022Q4	cbnt	Finite Lived Intangible Assets Net1 FiniteLivedIntangibleAssetsNet1	279918	usd
CY2021Q4	cbnt	Finite Lived Intangible Assets Net1 FiniteLivedIntangibleAssetsNet1	330421	usd
CY2022Q4	us-gaap	Goodwill Goodwill	350491	usd
CY2021Q4	us-gaap	Goodwill Goodwill	350491	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	50503	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	22095	usd
CY2022	us-gaap	Revenue From Related Parties RevenueFromRelatedParties		usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	50503	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	50503	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	50503	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	28409	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	179918	usd
CY2021Q4	cbnt	Original Issue Discount Rate OriginalIssueDiscountRate	0.10	pure
CY2021Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	825000	usd
CY2021Q4	cbnt	Warrant To Purchase Shares Of Common Stock WarrantToPurchaseSharesOfCommonStock	16500000	shares
CY2021Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.05
CY2021Q4	cbnt	Conversion Shares Percent conversionSharesPercent	0.50	pure
CY2021Q4	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	680000	usd
CY2021Q4	cbnt	Original Issued Discount Rate OriginalIssuedDiscountRate	75000	usd
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Two And Three LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwoAndThree	60000	usd
CY2021Q4	us-gaap	Legal Fees LegalFees	10000	usd
CY2022	cbnt	Future Financings Percentage FutureFinancingsPercentage	0.30	pure
CY2021Q4	us-gaap	Shares Issued SharesIssued	668151	shares
CY2022Q4	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	14064	usd
CY2022Q4	cbnt	Initial Warrant InitialWarrant	16500000	shares
CY2022Q4	us-gaap	Fair Value Hedges At Fair Value Net FairValueHedgesAtFairValueNet	347142	usd
CY2022Q4	cbnt	Original Issued Discount Rate OriginalIssuedDiscountRate	75000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Two And Three LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwoAndThree	60000	usd
CY2022Q4	us-gaap	Legal Fees LegalFees	10000	usd
CY2022Q4	cbnt	Aggregate Debt Discount AggregateDebtDiscount	145000	usd
CY2022Q4	us-gaap	Accelerated Share Repurchases Initial Price Paid Per Share AcceleratedShareRepurchasesInitialPricePaidPerShare	0.025
CY2022Q4	cbnt	Initial Warrants InitialWarrants	347142	usd
CY2022Q4	us-gaap	Common Stock Discount On Shares CommonStockDiscountOnShares	14064	usd
CY2022Q4	us-gaap	Debt Instrument Convertible Beneficial Conversion Feature DebtInstrumentConvertibleBeneficialConversionFeature	318794	usd
CY2022Q4	cbnt	Aggregate Noncash Debt Discount AggregateNoncashDebtDiscount	680000	usd
CY2022Q2	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	33000000	shares
CY2022Q2	cbnt	Original Issue Discount Rate OriginalIssueDiscountRate	0.10	pure
CY2022Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	825000	usd
CY2022Q2	us-gaap	Long Term Debt Maturity Date LongTermDebtMaturityDate	2022-10-15
CY2022Q2	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.04	pure
CY2022Q2	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.0125
CY2022Q2	cbnt	Conversion Price Per Share ConversionPricePerShare	0.00875
CY2022Q4	cbnt	Penalty Amount PenaltyAmount	206250	usd
CY2022Q4	us-gaap	Debt Instrument Redemption Price Percentage Of Principal Amount Redeemed DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed	0.25	pure
CY2022Q4	us-gaap	Interest And Debt Expense InterestAndDebtExpense	206250	usd
CY2022Q4	us-gaap	Long Term Debt Percentage Bearing Variable Interest Rate LongTermDebtPercentageBearingVariableInterestRate	0.18	pure
CY2022Q2	cbnt	Warrant To Purchase Shares Of Common Stock WarrantToPurchaseSharesOfCommonStock	16500000	shares
CY2022Q2	cbnt	Warrant To Purchase Shares Of Common Stock WarrantToPurchaseSharesOfCommonStock	33000000	shares
CY2022Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.025
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	3.485	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0116	pure
CY2022Q2	us-gaap	Debt Instrument Convertible Conversion Price Decrease DebtInstrumentConvertibleConversionPriceDecrease	0.011
CY2022Q2	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.011
CY2022Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.011
CY2022Q2	cbnt	Deemed Dividents DeemedDividents	3702	usd
CY2022Q3	us-gaap	Debt Instrument Convertible Conversion Price Decrease DebtInstrumentConvertibleConversionPriceDecrease	0.009
CY2022Q3	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.009
CY2022Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.009
CY2022Q3	cbnt	Current Exercise Price CurrentExercisePrice	0.011
CY2022Q3	cbnt	New Exercise Price NewExercisePrice	0.009
CY2022Q3	cbnt	Deemed Dividents DeemedDividents	733	usd
CY2022Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	104250	usd
CY2022Q4	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	100000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Two And Three LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwoAndThree	4250	usd
CY2022Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.22	pure
CY2022Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	64250	usd
CY2022Q4	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	60000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Two And Three LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwoAndThree	4250	usd
CY2022Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.22	pure
CY2022Q4	us-gaap	Debtor In Possession Financing Interest Rate On Borrowings Outstanding DebtorInPossessionFinancingInterestRateOnBorrowingsOutstanding	1.15	pure
CY2022Q4	us-gaap	Debtor In Possession Financing Interest Rate On Borrowings Outstanding DebtorInPossessionFinancingInterestRateOnBorrowingsOutstanding	1.25	pure
CY2022	cbnt	Conversion Of Percentage ConversionOfPercentage	0.65	pure
CY2022Q4	cbnt	Excess Outstanding Shares Percentage ExcessOutstandingSharesPercentage	0.0499	pure
CY2022Q4	cbnt	Aggregate Debt Premium AggregateDebtPremium	90731	usd
CY2022Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	938344	usd
CY2021Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	171875	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	83138	usd
CY2021Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	7052	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1199750	usd
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	825000	usd
CY2022	cbnt	Add Put Premium AddPutPremium	90731	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	7968	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	653125	usd
CY2022Q4	cbnt	Convertible Note Payable Net ConvertibleNotePayableNet	1282513	usd
CY2021Q4	cbnt	Convertible Note Payable Net ConvertibleNotePayableNet	171875	usd
CY2022Q4	cbnt	Less Current Portion Of Convertible Note Payable LessCurrentPortionOfConvertibleNotePayable	1031250	usd
CY2021Q4	cbnt	Less Current Portion Of Convertible Note Payable LessCurrentPortionOfConvertibleNotePayable	171875	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	251263	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	1899380	usd
CY2021Q4	us-gaap	Notes Payable NotesPayable	978925	usd
CY2022Q4	cbnt	Note Payable Ppp Note NotePayable_PppNote	18823	usd
CY2021Q4	cbnt	Note Payable Ppp Note NotePayable_PppNote	48929	usd
CY2022Q4	us-gaap	Notes And Loans Payable NotesAndLoansPayable	1918203	usd
CY2021Q4	us-gaap	Notes And Loans Payable NotesAndLoansPayable	1027854	usd
CY2022Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	132961	usd
CY2022Q4	us-gaap	Other Notes Payable OtherNotesPayable	1785242	usd
CY2021Q4	us-gaap	Other Notes Payable OtherNotesPayable	1027854	usd
CY2022Q4	cbnt	Less Current Portion Of Notes Payable LessCurrentPortionOfNotesPayable	-1576438	usd
CY2021Q4	cbnt	Less Current Portion Of Notes Payable LessCurrentPortionOfNotesPayable	-488414	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	208804	usd
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	539440	usd
CY2018Q4	cbnt	Proceeds From Notes Payables ProceedsFromNotesPayables	400000	usd
CY2018Q4	cbnt	Outstanding Interest Rate Percentage OutstandingInterestRatePercentage	0.18	pure
CY2022	cbnt	Loan Agreement Description LoanAgreementDescription	In the event that the Company’s accounts receivable balance plus inventory balance is less than paid principal balance of the Note as of December 31, 2018, the Company shall have 45 days (through and until February 15, 2019) to cure such violation and an establish accounts receivable plus inventory equal to the unpaid principal balance of the Note. Commencing March 31, 2019 and at all times thereafter through the remainder of the commitment period and for so long thereafter as there is any amount still due and owing under the Note, the Company must maintain an accounts receivable balances plus inventory such that the outstanding principal borrowed by Company under the Loan Agreement and Note is less than or equal to eighty five percent (85%) of accounts receivable plus fifty percent (50%) of inventory, all as measured at the same point in time.
CY2022Q4	cbnt	Note Balance Due NoteBalanceDue	400000	usd
CY2022	cbnt	Outstanding Interest Rate Percentage OutstandingInterestRatePercentage	0.18	pure
CY2022Q2	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	195000	usd
CY2022Q2	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	176000	usd
CY2022Q2	cbnt	Original Issue Discount And Investor Legal Fees OriginalIssueDiscountAndInvestorLegalFees	19000	usd
CY2022Q2	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	148420	usd
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1750000	shares
CY2022Q2	us-gaap	Debt Instrument Periodic Payment Principal DebtInstrumentPeriodicPaymentPrincipal	21060	usd
CY2022Q2	cbnt	Outstanding Interest Rate Percentage OutstandingInterestRatePercentage	0.08	pure
CY2022Q2	us-gaap	Debt Instrument Description DebtInstrumentDescription	GS Capital shall have the right at any time following an Event of Default to convert all or any part of the outstanding and unpaid principal, interest, penalties, and all other amounts under this Note at a conversion price of $0.011, subject to adjustment as defined in the GS Capital Note. The Company did not calculate a beneficial conversion feature since the GS Capital Note is contingently convertible upon default on the GS Capital Note. As of December 31, 2022, the Company is not in default on this note. In the event that following the Issue Date the closing trading price of the Company’s common stock is then being traded is below $0.011 per share for more than ten consecutive trading days, then the conversion price shall be equal to $0.004 per share. The GS Capital Note contains conversion limitations providing that a holder thereof may not convert the Note to the extent (but only to the extent) that, if after giving effect to such conversion, the holder or any of its affiliates would beneficially own in excess of 4.99% of the outstanding shares of the Company’s common stock immediately after giving effect to such conversion or exercise. A holder may increase or decrease its beneficial ownership limitation upon notice to the Company provided that in no event such limitation exceeds 9.99%, and that any increase shall not be effective until the 61st day after such notice. Events of default include, amongst other items, failure to pay principal or interest, bankruptcy, delisting of the Company’s stock, financial statement restatements, or if the Company effectuates a reverse split. Upon the occurrence of any event of default, the GS Capital Note shall become immediately and automatically due and payable and the Company shall pay to GS Capital, in full satisfaction of its obligations hereunder, an amount equal to: (a) the then outstanding principal amount of this note plus (b) accrued and unpaid interest on the unpaid principal amount of this note to the date of payment (the “mandatory prepayment date”) plus (y) default interest, if any, multiplied by 120%. On December 15, 2022, the Company and GS Capital entered into a letter agreement to extend the due date of the GS Capital June 2022 note by 60 days. Specifically, the maturity date of the GS Capital June 2022 note was extended to August 23, 2023 and the next payment due date was extended to February 28, 2023. Through December 31, 2022, the Company paid $53,512 of principal balance. On December 31, 2022, the principal balance due on the GS Capital Note amounted to $141,488 and accrued interest payable amounted to $7,471.On July 26, 2022, the Company closed a Securities Purchase Agreement (“July 2022 Agreement”) with GS Capital, pursuant to which a Promissory Note (“GS Capital July 2022 Note”) was made to GS Capital in the aggregate principal amount of $195,000. The GS Capital July 2022 Note was purchased for $176,000, reflecting an original issuance discount of $19,000, and was funded on July 28, 2022 (less legal and other administrative fees). The Company received net proceeds of $158,920. The Company further issued GS Capital a total of 2,600,000 commitment shares (“July 2022 Commitment Shares”) as additional consideration for the purchase of the July 2022 Note. In addition, the Company issued 998,008 of its common stock to the placement agent as fee for the capital raise, respectively. The July Commitment Shares and the placement agent shares were recorded as a debt discount of $34,606 based on the relative fair value method to be amortized over the life of the Note. Additionally, the GS Capital July 2022 Note is convertible upon an event of default into common shares at an initial effective conversion price which was lower than the fair value of common shares based on the quoted closing price of the Company’s common stock on the measurement date. Principal and interest payments shall be made in 10 installments of $21,060 each beginning on the 90th-day anniversary following the issue date and continuing thereafter each 30 days for nine months. The GS Capital July 2022 Note matures 12 months after issuance and bears interest at a rate of 8% per annum. GS Capital shall have the right at any time following an Event of Default to convert all or any part of the outstanding and unpaid principal, interest, penalties, and all other amounts under the GS Capital July 2022 Note at a conversion price of $0.011, subject to adjustment as defined in the Note. The Company did not calculate a beneficial conversion feature since the GS Capital July 2022 Note is contingently convertible upon a default on the July 2022 Note. As of December 31, 2022, the Company is not in default on this note.
CY2022Q3	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	195000	usd
CY2022Q3	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	176000	usd
CY2022Q3	cbnt	Original Issue Discount And Investor Legal Fees OriginalIssueDiscountAndInvestorLegalFees	19000	usd
CY2022Q3	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	158920	usd
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2600000	shares
CY2022Q3	us-gaap	Shares Issued SharesIssued	998008	shares
CY2022Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	34606	usd
CY2022Q3	us-gaap	Debt Instrument Periodic Payment Principal DebtInstrumentPeriodicPaymentPrincipal	21060	usd
CY2022Q3	cbnt	Outstanding Interest Rate Percentage OutstandingInterestRatePercentage	0.08	pure
CY2022Q3	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.011
CY2022Q3	us-gaap	Class Of Warrant Or Right Reason For Issuing To Nonemployees ClassOfWarrantOrRightReasonForIssuingToNonemployees	In the event that following the Issue Date the closing trading price of the Company’s common stock is then being traded is below $0.011 per share for more than ten consecutive trading days, then the conversion price shall be equal to $0.004 per share. The July 2022 Note contains conversion limitations providing that a holder thereof may not convert the Note to the extent (but only to the extent) that, if after giving effect to such conversion, the holder or any of its affiliates would beneficially own in excess of 4.99% of the outstanding shares of the Company’s common stock immediately after giving effect to such conversion or exercise. A holder may increase or decrease its beneficial ownership limitation upon notice to the Company provided that in no event such limitation exceeds 9.99%, and that any increase shall not be effective until the 61st day after such notice.
CY2022Q4	cbnt	Principal Amount PrincipalAmount	34120	usd
CY2022Q4	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	160880	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	6441	usd
CY2022Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	195000	usd
CY2022Q3	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	176000	usd
CY2022Q3	cbnt	Original Issue Discount And Investor Legal Fees OriginalIssueDiscountAndInvestorLegalFees	19000	usd
CY2022Q3	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	158920	usd
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3300000	shares
CY2022Q3	us-gaap	Shares Issued SharesIssued	773626	shares
CY2022	us-gaap	Conversion Of Stock Description ConversionOfStockDescription	The September Commitment Shares and the placement agent shares were recorded as a debt discount of $30,326 based on the relative fair value method to be amortized over the life of the Note. Additionally, the September 2022 Note is convertible into common shares upon an event of default at an initial effective conversion price which was lower than the fair value of common shares based on the quoted closing price of the Company’s common stock on the measurement date. Principal and interest payments shall be made in 9 installments of $23,400 each beginning on the 120th-day anniversary following the issue date and continuing thereafter each 30 days for eight months. The September 2022 Note matures 12 months after issuance and bears interest at a rate of 8% per annum. GS Capital shall have the right at any time following an Event of Default to convert all or any part of the outstanding and unpaid principal, interest, penalties, and all other amounts under the September 2022 Note at a conversion price of $0.009, subject to adjustment as defined in the Note. The Company did not calculate a beneficial conversion feature since the GS Capital July 2022 Note is contingently convertible upon a default on the September 2022 Note. As of December 31, 2022, the Company is not in default on this note. In the event that following the Issue Date the closing trading price of the Company’s common stock is then being traded is below $0.009 per share for more than ten consecutive trading days, then the conversion price shall be equal to $0.0032 per share. The September 2022 Note contains conversion limitations providing that a holder thereof may not convert the Note to the extent (but only to the extent) that, if after giving effect to such conversion, the holder or any of its affiliates would beneficially own in excess of 4.99% of the outstanding shares of the Company’s common stock immediately after giving effect to such conversion or exercise. A holder may increase or decrease its beneficial ownership limitation upon notice to the Company provided that in no event such limitation exceeds 9.99%, and that any increase shall not be effective until the 61st day after such notice. On December 15, 2022, the Company and GS Capital entered into a letter agreement to extend the due date of the GS Capital September 2022 note by 60 days. Specifically, the maturity date of the GS Capital September 2022 note was extended to November 6, 2023 and the next payment due date was extended to March 6, 2023. On December 31, 2022, the principal balance due on the GS Capital September 2022 Note amounted to $195,000 and accrued interest payable amounted to $5,001.
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.0075
CY2022	us-gaap	Deferred Sales Inducements Amortization Expense DeferredSalesInducementsAmortizationExpense	112500	usd
CY2021Q2	cbnt	Secured Promissory Note Amount SecuredPromissoryNoteAmount	500000	usd
CY2021Q2	cbnt	Annual Accrued Interest Percentage AnnualAccruedInterestPercentage	0.08	pure
CY2021Q2	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.18	pure
CY2021Q4	cbnt	Principal Amount PrincipalAmount	500000	usd
CY2021Q3	cbnt	Capital Lease Amount CapitalLeaseAmount	95013	usd
CY2022Q4	cbnt	Notes Payable Vehicles And Equipment Loans NotesPayableVehiclesAndEquipmentLoans	39513	usd
CY2021Q4	cbnt	Notes Payable Vehicles And Equipment Loans NotesPayableVehiclesAndEquipmentLoans	78925	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	121408	usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	usd
CY2022Q4	cbnt	Operating Leases Future Minimum Payment Due In Three Years OperatingLeasesFutureMinimumPaymentDueInThreeYears	1709400	usd
CY2022Q4	cbnt	Operating Leases Future Minimum Payment Due In Four Years OperatingLeasesFutureMinimumPaymentDueInFourYears	206457	usd
CY2022Q4	cbnt	Operating Leases Future Minimum Payment Due In Four And Five Years OperatingLeasesFutureMinimumPaymentDueInFourAndFiveYears	2346	usd
CY2022Q4	cbnt	Operating Leases Future Minimum Payment Due Thereafter OperatingLeasesFutureMinimumPaymentDueThereafter	1918203	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	957556	usd
CY2022	us-gaap	Dividends Dividends	19936	usd
CY2021	us-gaap	Dividends Dividends	14165	usd
CY2022	cbnt	Accrued Dividend Payable AccruedDividendPayable	36577	usd
CY2021	cbnt	Accrued Dividend Payable AccruedDividendPayable	16641	usd
CY2022	us-gaap	Dividends Cash DividendsCash	35719	usd
CY2021	us-gaap	Dividends Cash DividendsCash	32981	usd
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	51350	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	103800	usd
CY2021Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	103800	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	54000	usd
CY2022	cbnt	Stock Based Professional Fees StockBasedProfessionalFees	55000	usd
CY2022	cbnt	Professional Fees1 ProfessionalFees1	119321	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	119321	usd
CY2021	cbnt	Professional Fee ProfessionalFee	43250	usd
CY2021	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	38250	usd
CY2021	cbnt	Accretion Of Stockbased Professional Fees AccretionOfStockbasedProfessionalFees	5000	usd
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Expiration Date ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate	2022-05-01
CY2021Q3	cbnt	Value Of Restricted Stock Common Shares ValueOfRestrictedStockCommonShares	24413	usd
CY2021Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.025
CY2021	us-gaap	Dividends Share Based Compensation DividendsShareBasedCompensation	24413	usd
CY2021Q4	us-gaap	Stock Issued During Period Shares Restricted Stock Award Forfeited StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited	1000000	shares
CY2021Q4	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	30600	usd
CY2021Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.031
CY2022Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Forfeited StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited	500000	shares
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	14250	usd
CY2022Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.0285
CY2022Q3	us-gaap	Stock Issued During Period Shares Restricted Stock Award Forfeited StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited	1000000	shares
CY2022Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	11000	usd
CY2022Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.011
CY2022Q3	us-gaap	Stock Issued During Period Shares Restricted Stock Award Forfeited StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited	2000000	shares
CY2022Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	24000	usd
CY2022Q3	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	0.012	shares
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	82387	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	267530	usd
CY2022	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	16183	usd
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	23826926	shares
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.16
CY2021	cbnt	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Grants Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsGrantsNumberOfShares	6194767	shares
CY2021	cbnt	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Granted Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsGrantedWeightedAverageGrantDateFairValue	0.06
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	700000	shares
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	0.07
CY2021	cbnt	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Shares Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsSharesVestedNumberOfShares	-15051573	shares
CY2021	cbnt	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Shares Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsSharesVestedWeightedAverageGrantDateFairValue	-0.14
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	14270120	shares
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.14
CY2022	cbnt	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Grants Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsGrantsNumberOfShares	3500000	shares
CY2022	cbnt	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Granted Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsGrantedWeightedAverageGrantDateFairValue	0.014
CY2022	cbnt	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Shares Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsSharesVestedNumberOfShares	-800000	shares
CY2022	cbnt	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Shares Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsSharesVestedWeightedAverageGrantDateFairValue	-0.037
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	16970120	shares
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.119
CY2021Q3	cbnt	Acquired Percentage AcquiredPercentage	0.80	pure
CY2021Q3	cbnt	Average Of The Closing Prices AverageOfTheClosingPrices	800000	usd
CY2021Q2	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	3801224	shares
CY2021Q2	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	117838	usd
CY2021Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.031
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	668151	shares
CY2021Q4	cbnt	Amortization Of Debt Discount AmortizationOfDebtDiscount	14064	usd
CY2022Q1	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	823529	shares
CY2022Q1	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	823529	shares
CY2022Q1	cbnt	Amortization Of Debt Discount AmortizationOfDebtDiscount	12963	usd
	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	1750000	shares
	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	1750000	shares
	cbnt	Amortization Of Debt Discount AmortizationOfDebtDiscount	32736	usd
CY2022Q3	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	2600000	shares
CY2022Q3	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	998008	shares
CY2022Q3	cbnt	Aggregate Of Common Stock Issued AggregateOfCommonStockIssued	3598008	shares
CY2022Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	34606	usd
	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	3300000	shares
	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	773626	shares
	cbnt	Aggregate Of Common Stock Issued AggregateOfCommonStockIssued	4073626	shares
	cbnt	Amortization Of Debt Discount AmortizationOfDebtDiscount	30326	usd
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0075
CY2022	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount	112500	usd
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1500000	shares
CY2021Q4	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	120	shares
CY2021Q4	cbnt	Stated Redemption Value StatedRedemptionValue	12000	usd
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	0	usd
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	0	usd
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8445698	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.4
CY2021Q1	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	1008000	shares
CY2021Q4	cbnt	Aggregate Amount AggregateAmount	16500000	usd
CY2021Q4	cbnt	Warrants To Purchase Shares WarrantsToPurchaseShares	16500000	shares
CY2021Q4	cbnt	Exercise Price ExercisePrice	0.05
CY2021Q4	cbnt	Initial Warrants InitialWarrants	347142	usd
CY2022Q2	cbnt	Initial Warrants InitialWarrants	16500000	usd
CY2022Q2	cbnt	Purchase Of Shares PurchaseOfShares	33000000	shares
CY2022Q2	cbnt	Exercise Price ExercisePrice	0.025
CY2022	cbnt	Voting Percentage VotingPercentage	0.10	pure
CY2022	cbnt	Fair Market Percentage FairMarketPercentage	1.10	pure
CY2022	cbnt	Reported Revenue ReportedRevenue	102569	usd
CY2022	cbnt	Bad Debt Expenses BadDebtExpenses	102569	usd
CY2021Q3	us-gaap	Bankruptcy Claims Amount Of Claims Settled BankruptcyClaimsAmountOfClaimsSettled	16000	usd
CY2022Q4	us-gaap	Compensated Absences Liability CompensatedAbsencesLiability	18250	usd
CY2021Q4	us-gaap	Compensated Absences Liability CompensatedAbsencesLiability	18250	usd
CY2021Q1	cbnt	Bonus To Officers And Employee BonusToOfficersAndEmployee	330000	usd
CY2021Q3	us-gaap	Salaries And Wages SalariesAndWages	240000	usd
CY2021Q3	cbnt	Base Salaries Percentage BaseSalariesPercentage	0.50	pure
CY2022	cbnt	Base Salary Bonus Percentage BaseSalaryBonusPercentage	0.50	pure
CY2021Q4	cbnt	Aggregate Amount AggregateAmount	309615	usd
CY2021Q4	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.50	pure
CY2021Q4	us-gaap	Other Commitments Description OtherCommitmentsDescription	This bonus will be paid 10% in cash ($30,962) which was paid in December 2021 and 90% in equity amounting $278,653 which as of December 31, 2021 had been accrued and as of December 31, 2021, was included in accrued compensation on the accompanying consolidated balance sheet.
CY2022Q1	cbnt	Bonus Owed Executive Officers BonusOwedExecutiveOfficers	278653	usd
CY2022Q1	us-gaap	Preferred Stock Dividends Shares PreferredStockDividendsShares	278	shares
CY2022Q4	cbnt	Aggregate Amount AggregateAmount	160000	usd
CY2022Q4	us-gaap	Other Commitments Description OtherCommitmentsDescription	This bonus will be paid 10% in cash ($16,000) which was paid in December 2022 and 90% in equity amounting to $144,000 which as of December 31, 2022 had been accrued and as of December 31, 2022, was included in accrued compensation on the accompanying consolidated balance sheet.
CY2016Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.85
CY2022Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2022	cbnt	Customer Accounted Sales Percentage CustomerAccountedSalesPercentage	0.10	pure
CY2021	cbnt	Customer Accounted Sales Percentage CustomerAccountedSalesPercentage	0.442	pure
CY2021	cbnt	Number Of Customers NumberOfCustomers	1	pure
CY2021	cbnt	Concentration Risk Percentage ConcentrationRiskPercentage	0.214	pure
CY2022	cbnt	Number Of Suppliers NumberOfSuppliers	5	pure
CY2022	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	pure
CY2022	us-gaap	Revenues Revenues	2232646	usd
CY2021	us-gaap	Revenues Revenues	1476828	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	89219	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	45967	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1620089	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	282959	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-5156478	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-7128858	usd
CY2022Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	96306	usd
CY2021Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	135022	usd
CY2022	us-gaap	Revenues Net Of Interest Expense RevenuesNetOfInterestExpense	2232646	usd
CY2021	us-gaap	Revenues Net Of Interest Expense RevenuesNetOfInterestExpense	1476828	usd
	us-gaap	Payments For Rent PaymentsForRent	4444	usd
	us-gaap	Payments For Rent PaymentsForRent	4577	usd
CY2022	us-gaap	Debt Instrument Maturity Date Description DebtInstrumentMaturityDateDescription	On May 12, 2021 and effective June 1, 2021
CY2022Q2	us-gaap	Lease Cost LeaseCost	5283	usd
CY2022	cbnt	Lease Term LeaseTerm	P60M
CY2022	us-gaap	Payments For Rent PaymentsForRent	5600	usd
CY2021Q3	cbnt	Lease Agreemen Description LeaseAgreemenDescription	In September 2021, the Company entered into a 48-month lease agreement for the lease of office equipment under a non-cancelable operating lease through September 2025.
CY2021Q3	us-gaap	Payments For Rent PaymentsForRent	365	usd
CY2022Q1	cbnt	Lease Agreemen Description LeaseAgreemenDescription	In February 2022, the Company entered into a 36-month lease agreement for the lease of a vehicle under a non-cancelable operating lease through January 2025.
CY2022Q1	us-gaap	Payments For Rent PaymentsForRent	788	usd
CY2022	cbnt	Lease And Rental Expenses LeaseAndRentalExpenses	167875	usd
CY2021	cbnt	Lease And Rental Expenses LeaseAndRentalExpenses	119192	usd
CY2022Q4	cbnt	Office Leases Right Of Use Assets OfficeLeasesRightOfUseAssets	480293	usd
CY2021Q4	cbnt	Office Leases Right Of Use Assets OfficeLeasesRightOfUseAssets	269590	usd
CY2022Q4	us-gaap	Deferred Costs Leasing Accumulated Amortization DeferredCostsLeasingAccumulatedAmortization	104881	usd
CY2021Q4	us-gaap	Deferred Costs Leasing Accumulated Amortization DeferredCostsLeasingAccumulatedAmortization	18418	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	375412	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	251172	usd
CY2022Q4	cbnt	Lease Liabilities Related To Office Leases Right Of Use Assets LeaseLiabilitiesRelatedToOfficeLeasesRightOfUseAssets	376566	usd
CY2021Q4	cbnt	Lease Liabilities Related To Office Leases Right Of Use Assets LeaseLiabilitiesRelatedToOfficeLeasesRightOfUseAssets	251246	usd
CY2022Q4	cbnt	Less Current Portion Of Lease Liabilities LessCurrentPortionOfLeaseLiabilities	-117671	usd
CY2021Q4	cbnt	Less Current Portion Of Lease Liabilities LessCurrentPortionOfLeaseLiabilities	-44927	usd
CY2022Q4	cbnt	Lease Liabilities Longterm LeaseLiabilitiesLongterm	258895	usd
CY2021Q4	cbnt	Lease Liabilities Longterm LeaseLiabilitiesLongterm	206319	usd
CY2022Q4	cbnt	Operating Leases Future Minimum Payments Due Currents OperatingLeasesFutureMinimumPaymentsDueCurrents	147466	usd
CY2022Q4	cbnt	Operating Leases Future Minimum Payments Due In Two Year OperatingLeasesFutureMinimumPaymentsDueInTwoYear	149460	usd
CY2022Q4	cbnt	Operating Leases Future Minimum Payments Due In Three Year OperatingLeasesFutureMinimumPaymentsDueInThreeYear	100133	usd
CY2022Q4	cbnt	Operating Leases Future Minimum Payments Due In Four Year OperatingLeasesFutureMinimumPaymentsDueInFourYear	39200	usd
CY2022Q4	cbnt	Total Minimum Noncancelable Operating Lease Payments TotalMinimumNoncancelableOperatingLeasePayments	436259	usd
CY2022Q4	cbnt	Discount To Fair Value DiscountToFairValue	-59693	usd
CY2022Q4	cbnt	Total Lease Liability TotalLeaseLiability	376566	usd
CY2021Q4	us-gaap	Due To Officers Or Stockholders Noncurrent DueToOfficersOrStockholdersNoncurrent	3750	usd
CY2022Q2	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	250000	usd
CY2022Q2	cbnt	Net Proceeds NetProceeds	250000	usd
CY2022Q2	us-gaap	Investment Interest Rate InvestmentInterestRate	0.06	pure
CY2022Q2	us-gaap	Debt Conversion Original Debt Due Date Of Debt Day Month And Year DebtConversionOriginalDebtDueDateOfDebtDayMonthAndYear	2024-05-02
CY2022	us-gaap	Interest Expense Other InterestExpenseOther	10027	usd
CY2022Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	250000	usd
CY2022Q4	cbnt	Accrued Interest Payable AccruedInterestPayable	10027	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1081240	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1497060	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	506677	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	894825	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	574563	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	602235	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	2512665	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1938102	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	2512665	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1938102	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2512665	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1938102	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	11965000	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	574563	usd
CY2023Q1	cbnt	Accrued Compensation AccruedCompensation	53000	usd
	us-gaap	Subsequent Event Description SubsequentEventDescription	The Company has the right to prepay the March 2023 Diagonal Note (principal and accrued interest) at any time during the first six months the note is outstanding at the rate of 115% during the first 30 days after issuance, 120% during the 31st to 60th day after issuance, and 125% during the 61st to the 180th day after issuance.
CY2022Q4	us-gaap	Ownshare Lending Arrangement Shares Outstanding Value OwnshareLendingArrangementSharesOutstandingValue	65	usd
CY2022	cbnt	Stock Issued During Period Share Restricted Stock Award Gross StockIssuedDuringPeriodShareRestrictedStockAwardGross	4.99	shares
CY2022Q4	us-gaap	Due From Related Parties DueFromRelatedParties		usd
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent		usd
CY2021Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable		usd
CY2021Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022	cbnt	Research And Developments ResearchAndDevelopments		usd
CY2022	us-gaap	Other Nonoperating Income OtherNonoperatingIncome		usd
CY2021	cbnt	Stock Issued During Period Value Common Shares Issued For Cashless Warrant Exercise StockIssuedDuringPeriodValueCommonSharesIssuedForCashlessWarrantExercise		usd
CY2021	us-gaap	Paid In Kind Interest PaidInKindInterest		usd
CY2021	cbnt	Default Penalty Included In Interest Expense DefaultPenaltyIncludedInInterestExpense		usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown		usd
CY2022	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties		usd
CY2021	us-gaap	Increase Decrease In Due To Other Related Parties IncreaseDecreaseInDueToOtherRelatedParties		usd
CY2022	cbnt	Increase Decrease In Customer Deposit IncreaseDecreaseInCustomerDeposit		usd
CY2022	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition		usd
CY2022	cbnt	Proceeds From Sale Of Series C Preferred Stock ProceedsFromSaleOfSeriesCPreferredStock		usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2022	cbnt	Common Stock Issued For Accrued Compensation CommonStockIssuedForAccruedCompensation		usd
CY2022	cbnt	Deemed Dividend Related To Beneficial Conversion Feature Of Series C Preferred Shares DeemedDividendRelatedToBeneficialConversionFeatureOfSeriesCPreferredShares		usd
CY2021	cbnt	Increase In Debt Discount And Paidin Capital For Beneficial Conversion Feature On Convertible Debt IncreaseInDebtDiscountAndPaidinCapitalForBeneficialConversionFeatureOnConvertibleDebt		usd
CY2021	cbnt	Increase In Right Of Use And Lease Liability IncreaseInRightOfUseAndLeaseLiability		usd
CY2022	cbnt	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCash		usd
CY2022	cbnt	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivable		usd
CY2022	cbnt	Business Combination Recognized Identifiable Assets Acquired And Liabilitie Assumed Inventory BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitieAssumedInventory		usd
CY2022	cbnt	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Asset BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAsset		usd
CY2022	cbnt	Contract Assets ContractAssets		usd
CY2022	cbnt	Business Combination Recognized Identifiable Assets Acquired And Liabilitie Assumed Contract Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitieAssumedContractAssets		usd
CY2022	cbnt	Business Combination Recognized Right Of Use Assets BusinessCombinationRecognizedRightOfUseAssets		usd
CY2022	cbnt	Assets Acquired AssetsAcquired		usd
CY2022	cbnt	Business Combination Recognized Accounts Payable BusinessCombinationRecognizedAccountsPayable		usd
CY2022	cbnt	Business Combination Recognized Accrued Expenses BusinessCombinationRecognizedAccruedExpenses		usd
CY2022	cbnt	Business Combination Recognized Notes Payable BusinessCombinationRecognizedNotesPayable		usd
CY2022	cbnt	Business Combination Recognized Customer Deposit BusinessCombinationRecognizedCustomerDeposit		usd
CY2022	cbnt	Business Combination Recognized I Lease Liabilities BusinessCombinationRecognizedILeaseLiabilities		usd
CY2022	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders		usd
CY2022	cbnt	Business Combination Recognized Liabilities Assumed BusinessCombinationRecognizedLiabilitiesAssumed		usd
CY2022	cbnt	Net Liabilitie Assumed NetLiabilitieAssumed		usd
CY2022	cbnt	Fair Value Of Shares For Acquisition FairValueOfSharesForAcquisition		usd
CY2022	cbnt	Business Combination Recognized Increase In Intangible Assets Noncash BusinessCombinationRecognizedIncreaseInIntangibleAssetsNoncash		usd
CY2022Q4	us-gaap	Inventory Adjustments InventoryAdjustments		usd
CY2022	us-gaap	Intermediate Life Plants Useful Life IntermediateLifePlantsUsefulLife
CY2022	cbnt	Goodwill Useful Life GoodwillUsefulLife
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2021	cbnt	Add Put Premium AddPutPremium		usd
CY2021Q4	us-gaap	Long Term Debt LongTermDebt		usd
CY2021Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense		usd
CY2020Q4	cbnt	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Averages Remainings Contractuals Term5 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAveragesRemainingsContractualsTerm5
CY2020Q4	cbnt	Aggregate Intrinsic Values Balance Outstanding Ending AggregateIntrinsicValuesBalanceOutstandingEnding		usd
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022	cbnt	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriod
CY2022	cbnt	Aggregate Intrinsic Value Exercised AggregateIntrinsicValueExercised		usd
CY2022	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits		usd
CY2021	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001421636

Files In Submission

Name	View Source	Status
0001213900-23-025315-index-headers.html	Edgar Link	pending
0001213900-23-025315-index.html	Edgar Link	pending
0001213900-23-025315.txt	Edgar Link	pending
0001213900-23-025315-xbrl.zip	Edgar Link	pending
cbnt-20221231.xsd	Edgar Link	pending
f10k2022ex21-1_cbondsystems.htm	Edgar Link	pending
f10k2022ex23-1_cbondsystems.htm	Edgar Link	pending
f10k2022ex31-1_cbondsystems.htm	Edgar Link	pending
f10k2022ex31-2_cbondsystems.htm	Edgar Link	pending
f10k2022ex32-1_cbondsystems.htm	Edgar Link	pending
f10k2022ex32-2_cbondsystems.htm	Edgar Link	pending
f10k2022_cbondsystems.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
cbnt-20221231_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
cbnt-20221231_pre.xml	Edgar Link	unprocessable
f10k2022_cbondsystems_htm.xml	Edgar Link	completed
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
cbnt-20221231_cal.xml	Edgar Link	unprocessable
cbnt-20221231_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CBNT
C-Bond Systems, Inc Stock $cbnt

2023 Q1 Form 10-K Financial Statement

#000121390023025315 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CBNT C-Bond Systems, Inc Stock $cbnt

2023 Q1 Form 10-K Financial Statement

#000121390023025315 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CBNT
C-Bond Systems, Inc Stock $cbnt